Guardian Pharmacy Services (GRDN) Cash from Financing Activities (2023 - 2026)

Guardian Pharmacy Services has disclosed Cash from Financing Activities across 4 years of filings, most recently posting -$805000.0 for Q2 2026.

• In Q2 2026, Cash from Financing Activities rose 61.92% year-over-year to -$805000.0; the TTM figure through Jun 2026 stood at -$5.1 million (up 36.82% YoY), while the FY2025 annual figure was -$7.1 million, up 70.1% from the prior year.
• Cash from Financing Activities came in at -$805000.0 for Q2 2026 at Guardian Pharmacy Services, up from -$2.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $44.9 million in Q3 2024 to a low of -$48.3 million in Q4 2024.
• Average Cash from Financing Activities over 4 years is -$4.3 million, with a median of -$2.1 million recorded in 2025.
• Year-over-year, Cash from Financing Activities slumped 263.62% in 2024 and surged 98.43% in 2025.
• Over 4 years, Cash from Financing Activities stood at -$13.3 million in 2023, then tumbled by 263.62% to -$48.3 million in 2024, then surged by 98.43% to -$758000.0 in 2025, then slipped by 6.2% to -$805000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$805000.0 in Q2 2026, -$2.0 million in Q1 2026, and -$758000.0 in Q4 2025.